Clinical Trial Information
Coronado Biosciences is committed to bringing awareness and education of its clinical trials to patients and healthcare professionals.
Coronado, in accordance with US federal law, posts information about its clinical trials which includes information about the trial’s purpose, who may or may not participate in the trial, locations where the trial is being conducted around the world, and contact information for participating health care professionals. This National Institutes of Health registry database of clinical trials can be found on the following web page: www.clinicaltrials.gov.
If you are a patient, health care proxy, or healthcare professional looking for more information about current or planned clinical trials, you may visit the following websites:
For TSO (Trichuris suis ova or CNDO-201):
Phase 2 TRUST-II study in patients with Crohn's disease clinicaltrials/TRUST-II
Phase 1 MUCUS study in patients with Ulcerative Colitis clinicaltrials/MUCUS
Phase 2 study in patients with Ulcerative Colitis clinicaltrials/NIAID
Phase 2 HINT study in patients with Multiple Sclerosis clinicaltrials/HINT
Phase 2 TRIOMS study in patients with Multiple Sclerosis clinicaltrials/TRIOMS
Autism Spectrum Disorders
Phase 1 study in patients with Autism Spectrum Disorders clinicaltrials/ASD
Phase 1 study in patients with Psoriasis clinicaltrials/Psoriasis/Mount Sinai School of Medicine
Phase 1 study in patients with Psoriasis clinicaltrials/Psoriasis/Tufts Medical Center
For CNDO-109-Activated Allogeneic Natural Killer Cells (aaNK):
Phase 1/2 study for patients with Acute Myeloid Leukemia clinicaltrials/aaNK
or complete the "Contact Us" information below and a Coronado representative will contact you to provide the requested information.